Clinical advances in immunotherapy for immune-mediated glomerular diseases

ConclusionCertain immunotherapeutic drugs, such as rituximab, belimumab, and eculizumab, have exhibited notable efficacy in treating specific immune-mediated glomerular diseases, thereby providing novel therapeutic approaches for patients. Nonetheless, the efficacy of numerous immunotherapeutic drugs remains to be substantiated.
Source: Clinical and Experimental Medicine - Category: Research Source Type: research